The effects of tumor treating fields and temozolomide in MGMT expressing and non-expressing patient-derived glioblastoma cells

Highlights • Tumor treating fields (TTFs) & temozolomide (TMZ) in TMZ resistant & sensitive cells. • All cell lines were equally sensitive to the inhibitory effects of TTFs. • Inhibitory effect of TTFs was independent of TMZ and did not overcome TMZ resistance. • The optimum frequency for TT...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical neuroscience 2017-02, Vol.36, p.120-124
Hauptverfasser: Clark, Paul A, Gaal, Jordan T, Strebe, Joslyn K, Pasch, Cheri A, Deming, Dustin A, Kuo, John S, Robins, H. Ian
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Highlights • Tumor treating fields (TTFs) & temozolomide (TMZ) in TMZ resistant & sensitive cells. • All cell lines were equally sensitive to the inhibitory effects of TTFs. • Inhibitory effect of TTFs was independent of TMZ and did not overcome TMZ resistance. • The optimum frequency for TTFs (200 kHz) was the same frequency used clinically.
ISSN:0967-5868
1532-2653
DOI:10.1016/j.jocn.2016.10.042